Menopause and Joint Pain: Why It Happens and What Actually Helps

If you've hit your mid-40s and your hips are stiff getting out of the car, your shoulders ache every morning, and something hurts in a way it never used to, you've probably had one of two responses. Either you were fobbed off entirely, or you were told it's the menopause and left there.

Neither one gives you anything to do. Joint pain rises sharply through perimenopause, the mechanism is hormonal, and as of 2024 it has a proper clinical name. What to do about it is where most advice goes wrong, in both directions. Here's what the research actually supports, including the parts it supports less strongly than you'll read elsewhere.

Here are 5 things to know about menopause and joint pain:

1. Joint pain in perimenopause is common enough to be considered part of the transition, not bad luck or bad genes

2. It has a clinical name now, and knowing it changes the conversation you can have with your GP

3. Oestrogen affects far more than cartilage: muscle, tendon, the joint lining and bone are all involved, which is why this doesn't behave like a normal injury

4. Resting is the one response the evidence clearly rules out, but that doesn't mean training hard is the answer either

5. The strongest reason to load your joints isn't pain relief, it's holding on to the muscle and bone that menopause is taking

 How common is joint pain in menopause?

Common enough that it should probably be treated as a standard feature of the transition. In January 2026, a systematic review and meta-analysis published in JBJS Open Access pooled 37 studies covering 93,021 women across 22 countries. Muscle or joint pain affected 40% of premenopausal women (95% CI 32-49), 57% of perimenopausal women (48-65) and 59% of postmenopausal women (50-67) (PMC12784006, JBJS Open Access, 2026).

Expressed as relative risk, perimenopausal women were 1.35 times more likely to report musculoskeletal pain than premenopausal women, and postmenopausal women 1.40 times more likely. Back pain followed almost the same curve: 42% before, 57% during, 59% after.

A separate retrospective review in 2023 found arthralgia in 51.5% of premenopausal women, 62.4% after natural menopause and 73.3% after surgical or medical menopause (PubMed 37127408, Post Reproductive Health, 2023). That last figure matters. When the ovaries are removed and oestrogen drops off a cliff rather than tapering, joint pain gets worse. It's one of the clearest signals that this is hormonal rather than simply chronological.

There is more on exercise through perimenopause in a separate post if you want the wider picture.

What is the musculoskeletal syndrome of menopause?

In October 2024, a paper in Climacteric proposed a collective name for a group of symptoms clinicians kept seeing arrive together: joint pain, loss of muscle mass, loss of bone density, and faster progression of osteoarthritis. Wright and colleagues called it the musculoskeletal syndrome of menopause, and estimated that more than 70% of women experience musculoskeletal symptoms through the transition, with around 25% disabled by them (PubMed 39077777, Climacteric 27(5), 2024).

Naming it does something useful. Four separate complaints, raised at four separate appointments, get four separate dismissals. One syndrome with a hormonal driver is a different conversation. More than 47 million women worldwide enter the menopause transition every year, and until recently there was no shared term for the most physically limiting part of it.

If you take one thing from this post into a GP appointment, take the phrase. Saying "I think this might be the musculoskeletal syndrome of menopause" is a different opening to "my joints hurt." It signals that you've connected the symptoms to each other and to your hormones, and it's a term from a peer-reviewed journal rather than a wellness blog.

Why does oestrogen affect your joints?

Because oestrogen receptors aren't confined to the reproductive system. They're present in cartilage, subchondral bone, the synovium (the joint lining), muscle and tendon (Climacteric, 2016). When oestrogen falls, all of those tissues are affected at once, which is why menopausal joint pain rarely behaves like a single-joint injury.

The detail is more specific than most explanations suggest. Oestrogen influences cartilage through growth factors, inflammatory cytokines, matrix metalloproteinases (particularly MMP-13, which breaks down collagen), and reactive oxygen species. In tendon, oestrogen affects collagen synthesis and the mechanical properties of the tissue itself, demonstrated in postmenopausal women using isotope tracing, microdialysis and MRI (PubMed 18927264, J Appl Physiol, 2008).

You'll read in a lot of places that oestrogen "lubricates the joints" and they "dry out" at menopause. It's a tidy image and it isn't what happens. The changes are in tissue composition, inflammation and repair capacity, not in lubrication.

The downstream effect is measurable. Postmenopausal women develop osteoarthritis at nearly twice the rate of age-matched men (npj Women's Health, 2025).

Which joints does menopause affect most?

Shoulders, hips and glutes, then knees, hands and lower back. Back pain has the clearest research numbers, moving from 42% to 59% across the transition, but it isn't what walks through the studio door most often.

Shoulder problems are hugely prevalent at this age. There's a significant presence of oestrogen receptors in the shoulder capsule and its surrounding connective tissue, and the capsule does seem disproportionately affected when oestrogen drops, which would go some way to explaining it. Nobody fully understands the mechanism yet. Then glutes and hips. Gluteal tendinopathy is common in menopause, and so is general hip joint pain. My own hips have been very stiff in the mornings since menopause, which is not a symptom I ever expected to have opinions about.

The research partly backs the shoulder observation. One study included in the 2026 review found shoulder synovitis, meaning inflammation of the joint lining, in 25.1% of perimenopausal women against 6.2% of premenopausal women. That's a large gap, but it comes from a single study rather than a pooled finding, so treat it as suggestive rather than settled. The wider point about oestrogen receptor density in the shoulder capsule specifically is a reasonable inference from clinical patterns, not something the literature has nailed down.

Adhesive capsulitis affects around 2% to 5% of the general population, the mean age of onset is about 55, and women get it more often than men, at a ratio of roughly 1.4 to 1 (StatPearls). In a cohort of 2,190 patients, 58.4% were women, with an average age of 56.4 and most cases falling between 40 and 70 (PubMed 29807717, J Shoulder Elbow Surg, 2018).

So the overlap with the menopause window is real, and the mechanism is plausible. But note the size of the gap: women are more likely to get frozen shoulder, not overwhelmingly so. The specific claim you'll see repeated online, that frozen shoulder is five times more common in menopausal women, doesn't trace back to a study anyone can point to. It's a topic worth its own post rather than a statistic worth repeating.

Should you rest or keep moving?

Keep moving. Rest is the one response the evidence rules out clearly, and the case against it is strong across several lines of research.

Extended inactivity drives loss of bone density, lean mass, leg strength and cardiovascular fitness, and raises the risk of falls and fractures (PMC4600281, 2015). Bed-rest trials, which are the cleanest way to study this, show that resistance and impact exercise prevent those losses. In a menopausal woman already losing muscle and bone to falling oestrogen, resting an aching joint compounds a problem that's already underway.

Loading also helps the pain. A 2025 network meta-analysis of 28 RCTs and 2,164 participants found resistance training reduced osteoarthritis pain with a standardised mean difference of -0.57 (95% CrI -0.65 to -0.49), comfortably exceeding the minimum clinically important difference of 0.37. Women benefited more than men (PMC12436098, Frontiers in Public Health, 2025).

And loading doesn't damage the joint. The START trial measured knee joint compressive forces directly rather than assuming: high-intensity strength training produced forces of 2453 N compared with 2512 N in controls (p=0.61). No increase. The common fear that lifting will wear the joint out faster isn't supported.

The dose. Three sessions a week, 20 to 90 minutes, for a minimum of six to eight weeks, is what the research consistently uses (PMC10647115, BMC Women's Health, 2023). On weekly volume the picture is more interesting: the dose-response curve is U-shaped, not linear. The minimum effective dose is around 280 METs-minutes per week (SMD -0.36), the optimum is around 680 (SMD -0.73), and above roughly 1,180 the benefit halves back to -0.37.

More is not better. Enough is better, and then more becomes worse again. The review authors rated the evidence quality as low, so treat those numbers as a sensible target rather than a prescription.

In practice the women who come to me split almost exactly down the middle, and the two halves need opposite advice. Roughly half have decided the answer is to work harder in the gym, usually more cardio, and they need encouraging to do less. The other half have stopped and are doing much less, and they need encouraging not to be frightened of doing more. Use it or lose it is a very real thing at this age.

That's why generic advice fails here. "Rest more" is exactly wrong for one group. "Push through" is exactly wrong for the other. Which half you're in is the first thing worth working out, and it usually takes about ten minutes of conversation rather than any kind of test.

Degenerative discs, gluteal tendinopathy, and other frightening words

A lot of women arrive having been given a term by their GP or a specialist that has genuinely frightened them. "Degenerative discs" is the one I hear most. "Gluteal tendinopathy" is another. Both sound permanent, both sound like damage, and both send people straight to the internet at eleven at night.

What each of those terms actually describes is a tissue asking for more attention than it's currently getting. That's it. Not a verdict, not a countdown. A message that something needs addressing, whether that's how you're moving, what you're eating, how much stress you're carrying, or more likely some combination of the three.

The word "degenerative" is particularly unhelpful, because disc changes show up on scans of plenty of people with no pain at all. A term describing what a scan looks like is not the same as a term describing what your body can do.

This matters practically, not just emotionally. Fear changes behaviour. A woman who believes her spine is crumbling stops loading it, and that's the response the evidence rules out. The label ends up causing more harm than the tissue.

If you've been given a word that scared you, it's worth asking whoever gave it to you what it means for what you can do, rather than what it means for what you have.

What the evidence doesn't show

Most articles on this topic will tell you strength training fixes menopausal joint pain. The honest position is narrower, and it's worth knowing before you start so you don't conclude you've failed when the results are modest.

Heavier isn't better. The START trial (JAMA, 2021) randomised 377 people with knee osteoarthritis to high-intensity strength training, low-intensity strength training, or attention control for 18 months, with blinded assessors. High intensity produced no better pain outcomes than low intensity or control (WOMAC 5.1 vs 4.4 vs 4.9; high intensity vs control p=0.61). Adverse events were higher in the high-intensity group: 53, against 30 and 4 (PubMed 33591346, JAMA, 2021).

In postmenopausal women specifically, targeted protocols have twice failed to beat sham exercise. The GLoBE trial randomised 81 postmenopausal women with lateral hip pain to gluteal loading or sham exercise. No difference between groups. Both improved significantly at 12 weeks and again at 52 (Ganderton et al., J Womens Health, 2018). A 2022 factorial trial in 132 postmenopausal women compared tendon-specific exercise with sham exercise, with and without HRT. Every group improved. No difference between the exercise groups (AJSM, 2022).

Worth sitting with that for a moment, because gluteal tendinopathy and lateral hip pain are among the most common presentations in this age group. The two trials that looked hardest at the condition women actually have found that the clever targeted protocol performed no better than the placebo version of itself.

Worth noting what all those arms had in common: education and guidance on managing load. The most straightforward reading is that doing something consistently, with someone sensible advising you on how much, is what produces the result. The specific protocol matters less than the industry selling protocols would like.

The benefit may not last. A Cochrane review found exercise reduces knee osteoarthritis pain by about 12 points out of 100, but the effect peaks at around two months and is no better than usual care by nine (PubMed 26405113). Adherence, not programme design, is the thing that determines outcomes.

And the largest gap of all: the January 2026 meta-analysis searched the literature and found only observational studies. Thirty-five cross-sectional, two cohort, and not one randomised controlled trial testing any intervention against the musculoskeletal symptoms of perimenopause as a primary outcome. Every recommendation in this article, including mine, is inference from adjacent research: osteoarthritis trials, sarcopenia trials, bed-rest studies. That's a legitimate basis for advice. It isn't direct evidence, and anyone telling you otherwise hasn't checked.

 Does HRT help, and what about supplements?

HRT helps a little. The Women's Health Initiative randomised 10,739 women to oestrogen alone or placebo and tracked joint symptoms. At one year, 76.3% of the oestrogen group reported joint pain against 79.2% on placebo (p=0.001). Statistically significant, and from a genuine large-scale RCT, which is rare in this field (PubMed 23511705, WHI, 2013).

Then look at the size of it. The difference in severity was 0.06 points on a 0 to 3 scale at year one, and 0.14 by year three. Joint swelling was actually significantly higher on oestrogen. So: real, but small, and not a replacement for muscle.

Where HRT does look powerful is alongside training rather than instead of it. In a 2021 trial, 12 weeks of supervised resistance training three times a week in early postmenopausal women produced a 3.9% increase in quadriceps cross-sectional area and 2.9% in fat-free mass on placebo. With transdermal oestrogen, the same programme produced 7.4% and 5.5% (PMC7853242, Frontiers in Physiology, 2021). Small study, 31 women, but the direction is consistent: HRT amplifies training. It doesn't substitute for it.

Supplements are where the gap is widest between what's sold and what's shown. A 2023 meta-analysis of 27 RCTs covering 1,989 menopausal women compared interventions head to head. Exercise produced a large effect on handgrip strength (SMD 0.901) and a solid one on knee extension strength (0.698). Vitamin D produced a small effect. Protein supplementation wasn't statistically significant at all (SMD 0.074, 95% CI -0.267 to 0.414).

If you're choosing between a protein powder and three sessions a week, the research isn't ambiguous.

What to expect at Shaw Lifestyle

Here's the reframe that matters, and it's the reason the Strength Foundations Block (£220) is the right starting point rather than a series of pain-management sessions.

The strongest argument for loading isn't pain relief. Given the null trials above, promising pain relief would be overselling it. The strongest argument is that menopause is taking muscle and bone, and loading is the only thing that reliably slows that down. Lean mass declines by around 0.2% a year through the transition, roughly 1.9% cumulatively across the three and a half years or so it typically lasts, and the rate of fat gain doubles about two years before the final period (SWAN, JCI Insight, 2019).

Pain relief is a likely bonus with a modest effect size. Keeping your muscle is the actual objective, and it's not optional.

The block runs on the structure the research supports: progressive resistance work, supervised, at a frequency and volume that matches the effective dose rather than exceeding it. There is more on strength training for women over 40 in a separate post.

A first session starts with working out which half you're in, because that determines everything that follows. It also usually involves untangling what you've already been told. There's far more open conversation about menopause now than there was even five years ago, but GP knowledge and understanding is still very mixed. That isn't a criticism. They're carrying enormous workloads, and anything hormonal is genuinely complex. It does mean the advice women arrive with varies enormously depending on who they happened to see.

For anyone with an existing diagnosis, an acute flare, or a joint that's already been imaged or investigated, Corrective Exercise sessions (£65 per session) are the better place to start. Individual assessment first, loading second.

To talk through your situation before booking, book a call with Liz.

Frequently asked questions

What does menopause joint pain feel like?

Typically stiffness that's worse in the morning and eases with movement, affecting several joints at once rather than one, and often symmetrical. Hips, knees, shoulders, hands and lower back are the usual sites. It differs from injury pain in that there's no incident to point to and no single joint responsible. If one joint hurts sharply after a specific event, that's a different problem worth investigating separately.

Will joint pain from menopause go away?

Not on its own, for most women. The 2026 meta-analysis found prevalence slightly higher after menopause (59%) than during perimenopause (57%), so the symptoms don't resolve when periods stop (PMC12784006, 2026). What the data does show is that it's modifiable. Resistance training reduces osteoarthritis pain by a clinically meaningful margin, and women respond better than men.

Does HRT help joint pain?

Slightly. The Women's Health Initiative RCT found joint pain in 76.3% of women on oestrogen against 79.2% on placebo (p=0.001), but the difference in severity was 0.06 points on a 0 to 3 scale, and joint swelling was higher on oestrogen (PubMed 23511705, 2013). Statistically real, clinically marginal. HRT appears more useful for amplifying the results of strength training than for treating joint pain directly.

Should I rest or exercise with menopausal joint pain?

Exercise, but not intensely. Rest drives loss of bone density, muscle and strength, which worsens the underlying problem. However, high-intensity training performed no better than low-intensity in the START trial and caused more adverse events. Three sessions a week at moderate intensity, sustained for at least six to eight weeks, is what the evidence supports.

Which joints does menopause affect most?

Shoulders, hips and glutes, then knees, hands and lower back. Back pain has the clearest data, rising from 42% before menopause to 59% after. Shoulders may be disproportionately affected: one study found synovitis in 25.1% of perimenopausal women compared with 6.2% premenopausal, though that comes from a single study. Gluteal tendinopathy and general hip joint pain are both common in this age group. Frozen shoulder has a mean onset age of around 55 and affects women more often than men, at a ratio of roughly 1.4 to 1.

The evidence, stated plainly

Joint pain in perimenopause is common, hormonal, and now has a name. Oestrogen acts on cartilage, bone, joint lining, muscle and tendon, which is why it doesn't behave like an ordinary injury.

Rest makes it worse. Loading helps, though less dramatically than most articles claim, and no trial has yet tested any intervention against menopausal joint pain specifically. What loading definitely does is protect the muscle and bone that menopause is taking, and that's the reason to start regardless of what happens to the pain.

Shaw Lifestyle's Strength Foundations Block and Corrective Exercise sessions are available to book directly. To talk through your situation first, book a call with Liz.

Sources

- [PMC12784006: Musculoskeletal Manifestations of Perimenopause, Systematic Review and Meta-analysis, 93,021 women, 37 studies, 22 countries, JBJS Open Access, January 2026](https://pmc.ncbi.nlm.nih.gov/articles/PMC12784006/)

- [PubMed 39077777: The musculoskeletal syndrome of menopause, Wright et al., Climacteric 27(5):466-472, October 2024](https://pubmed.ncbi.nlm.nih.gov/39077777/)

- [PubMed 37127408: Arthralgia of menopause, a retrospective review, Post Reproductive Health, 2023](https://pubmed.ncbi.nlm.nih.gov/37127408/)

- [PubMed 23511705: Estrogen alone and joint symptoms in the Women's Health Initiative randomised trial, n=10,739, 2013](https://pubmed.ncbi.nlm.nih.gov/23511705/)

- [PubMed 33591346: START trial, high-intensity strength training and knee osteoarthritis, RCT n=377, JAMA, 2021](https://pubmed.ncbi.nlm.nih.gov/33591346/)

- [PubMed 26405113: Exercise for osteoarthritis of the knee, Cochrane systematic review, 2015](https://pubmed.ncbi.nlm.nih.gov/26405113/)

- [Ganderton et al.: GLoBE trial, gluteal loading versus sham exercise in postmenopausal women, n=81, J Womens Health, 2018](https://espace.library.uq.edu.au/view/UQ:e7e4fbd/UQe7e4fbd_OA.pdf)

- [AJSM 2022: Menopausal hormone therapy and exercise in postmenopausal women with greater trochanteric pain syndrome, 2x2 factorial RCT, n=132](https://journals.sagepub.com/doi/10.1177/03635465211061142)

- [PMC12436098: Optimising resistance training for pain management in knee and hip osteoarthritis, network meta-analysis, 28 RCTs, Frontiers in Public Health, 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12436098/)

- [PMC10647115: Non-pharmacological interventions for sarcopenia prevention in menopausal women, 27 RCTs, 1,989 women, BMC Women's Health, 2023](https://pmc.ncbi.nlm.nih.gov/articles/PMC10647115/)

- [PMC7853242: Transdermal estrogen therapy improves gains in skeletal muscle mass after 12 weeks of resistance training, Frontiers in Physiology, 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC7853242/)

- [SWAN: Changes in body composition and weight during the menopause transition, JCI Insight, 2019](https://insight.jci.org/articles/view/124865)

- [Climacteric 2016: Estrogen, menopause and joints, narrative review](https://www.tandfonline.com/doi/full/10.3109/13697137.2016.1151151)

- [npj Women's Health 2025: The intersection of aging and estrogen in osteoarthritis](https://www.nature.com/articles/s44294-025-00063-1)

- [PubMed 18927264: Effect of estrogen on tendon collagen synthesis in postmenopausal women, J Appl Physiol, 2008](https://pubmed.ncbi.nlm.nih.gov/18927264/)

- [PMC4600281: The impact of extended bed rest on the musculoskeletal system, 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC4600281/)

- [StatPearls: Adhesive Capsulitis (Frozen Shoulder), prevalence and sex ratio](https://www.ncbi.nlm.nih.gov/books/NBK532955/)

- [PubMed 29807717: Shoulder adhesive capsulitis, epidemiology and predictors of surgery, cohort of 2,190 patients, J Shoulder Elbow Surg, 2018](https://pubmed.ncbi.nlm.nih.gov/29807717/)